EGFR and hepatocellular carcinoma: Another research study reported that knockout of reticulocalbin‐2, a protein that interacts with EGFR, in hepatocellular carcinoma cells not only inhibited activation of the EGFR–ERK pathway but also suppressed cell proliferation under conditions of prolonged exposure to EGF 25.